3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline

    February 2025 in “ Advanced Healthcare Materials ”
    Xingyun Yang, Mara Artibani, Yongcheng Jin … Hagan Bayley
    Studysummary This study developed microfluidics-based 3D microtumors to model minimal residual disease in ovarian cancer, highlighting their alignment with patient-derived MRD and response to a fatty acid oxidation inhibitor.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on advanced.onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Bead-Jet Printing Enabled Sparse Mesenchymal Stem Cell Patterning Augments Skeletal Muscle and Hair Follicle Regeneration Nature Communications · 2022